Physician profile
Daniel Caleb Persinger
NPI 1780939462
$7,946.40
in general payments reported to CMS, 2019-2025
11 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $50.60 · 2022: $7,362 · 2023: $192 · 2024: $158 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $533.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,303.62 | 2022 | |
| Smith+Nephew, INC. | $278.82 | 2021-2025 | Collagenase Santyl, Renasys Go V2 Home, Renasys Touch |
| Medtronic, INC. | $110.78 | 2023 | Interstim |
| Conmed Corporation | $89.85 | 2024 | Airseal |
| Integra Lifesciences Corporation | $45.14 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Vertex Pharmaceuticals Incorporated | $30.91 | 2025 | |
| Avita Medical Americas, LLC | $29.40 | 2023 | Recell |
| Acera Surgical, INC. | $19.07 | 2024 | Restrata Wound Matrix |
| Novo Nordisk INC | $15.47 | 2025 | Wegovy |
| Paratek Pharmaceuticals, INC. | $11.94 | 2022 | |
| Kci USA, INC. | $11.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Persinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.